Bio-Rad Share Price

Bio-Rad Share Price

NYSE: BIO | Mid Cap | Healthcare
$359.05
-$8.19 (-2.23%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Bio-Rad Stock Performance

Open
$365.70
Prev. Close
$367.24
Circuit Range
N/A
Day Range
$357.63 - $367.62
Year Range
$238.96 - $396.23
Volume
10,012
Average Traded
$363.00

Bio-Rad Share Price Today

As of 21 November 2026, Bio-Rad Laboratories, Inc.Class A's share price is $359.05. The stock opened at $365.70, compared to its previous close of $367.24. During today's trading session, Bio-Rad Laboratories, Inc.Class A's share price traded between $357.63 and $367.62, with an average price of $362.62. Over the past 52 weeks, the stock has recorded a high of $396.23 and a low of $238.96. In terms of performance, Bio-Rad Laboratories, Inc.Class A's share price has risen by 15.12% over the last six months and is up 10.38% on a year-on-year basis.

Bio-Rad Share Price Chart

Line chart of the Bio-Rad price trend over the selected period. The price fell overall, ranging from 357.56 to 368.06, ending at 359.05.
$357.63$367.62
L
Show Current Price
H

Bio-Rad Stock Fundamentals & Key Indicators

Market Cap
$9.79B
PE Ratio (TTM)
9.66
Dividend Yield
0.00%
EPS (TTM)
$38.04
Revenue (TTM)
$2.58T
Return On Equity (TTM)
13.45%
Profit Margin
29.42%
Debt to Equity
0.16
Quarterly Earnings Growth YoY
-36.31%

Bio-Rad Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$693.20$592.10$651.00$656.40
Net Profit$720.00-$527.10$371.40$458.60
Net Profit Margin103.87%-89.02%57.05%69.87%
Income ChangeN/A-173.21%170.46%23.48%

Bio-Rad Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2802.20$2671.20$2566.50$2583.20
Net Profit-$3627.50-$637.30-$1844.20$759.90
Net Profit Margin-129.45%-23.86%-71.86%29.42%
Income ChangeN/A82.43%-189.38%141.20%

Bio-Rad Balance Sheet

All figures in USD Billion

Particulars2025202420232022
Non Current Assets7.676.339.2510.34
Current Assets2.913.033.053.16
Total Assets10.589.3612.313.5
Non Current Liabilities2.612.333.043.32
Current Liabilities0.520.470.520.57
Total Liabilities3.122.793.563.89
Shareholders' Equity7.456.578.749.62

Bio-Rad Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating532.2455.2374.9194.4
Investing-189.7-160.220.2-1,207.6
Financing-283.2-218.8-425.6973.6

About Bio-Rad

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Bio-Rad Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$373.15
$358.27
-3.92%
Oct 2026
$370.87
$372.90
-1.48%
Sep 2026
$382.71
$378.51
-2.85%
Aug 2026
$326.10
$389.63
+19.69%
Jul 2026
$294.25
$325.52
+10.97%
Jun 2026
$309.15
$293.34
-5.95%
May 2026
$262.18
$311.89
+11.33%
Apr 2026
$279.51
$280.15
+0.48%
Mar 2026
$274.80
$278.80
+0.18%
Feb 2026
$292.19
$278.31
-5.29%
Jan 2026
$303.37
$293.86
-3.19%
Dec 2025
$325.25
$303.53
-6.69%

Bio-Rad Share Price FAQs